If you find this podcast useful please give it a rating and review on iTunes by clicking here
Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app
On today's Vox Markets Podcast: Maurice Treacy from Open Orphan and Alan Green on 4 Stocks
Maurice Treacy, Chief Commercial Officer of Open Orphan (ORPH) discusses their agreement with Empiric Logic to complete the build out of their Health Data platform, Europe's first rare disease, advocacy-led genomic database.
Open Orphan plc is a European-focused, rare and orphan drug consulting services platform. The Company intends to roll up a number of orphan drug services business. Open Orphan has two data driven digital platforms, a Genomic Health Data Platform, which is establishing a rare disease database and a Virtual Rep platform enabling pharmaceutical companies to engage key opinion leaders and physicians. The Company is targeting rapid growth in one of the fastest growing sectors in the global pharmaceutical industry targeting under-supplied treatment for life threatening or very serious diseases and rare disorders.
Alan Green CEO of Brand Communications talks about:
Fair Oaks Income (FAIR)
Open Orphan (ORPH)
Helios Underwriting (HUW)
Kibo Mining (KIBO)
(Interview starts at 9 minutes 54 seconds)